CN Patent

CN104395307A — 地匹福林盐酸盐的稳定型晶体及其结晶化方法

Assigned to Taiho Pharmaceutical Co Ltd · Expires 2015-03-04 · 11y expired

What this patent protects

本发明的课题在于得到5-氯-6-[(2-亚氨基吡咯烷-1-基)甲基]嘧啶-2,4(1H,3H)-二酮一盐酸盐的稳定型晶体，作为其解决手段，提供一种5-氯-6-[(2-亚氨基吡咯烷-1-基)甲基]嘧啶-2,4(1H,3H)-二酮一盐酸盐的晶体，以粉末X射线衍射的衍射角(2θ±0.1°)表示，在11.6°、17.2°、17.8°、23.3°、27.1°和29.3°处观察到特征峰。

USPTO Abstract

本发明的课题在于得到5-氯-6-[(2-亚氨基吡咯烷-1-基)甲基]嘧啶-2,4(1H,3H)-二酮一盐酸盐的稳定型晶体，作为其解决手段，提供一种5-氯-6-[(2-亚氨基吡咯烷-1-基)甲基]嘧啶-2,4(1H,3H)-二酮一盐酸盐的晶体，以粉末X射线衍射的衍射角(2θ±0.1°)表示，在11.6°、17.2°、17.8°、23.3°、27.1°和29.3°处观察到特征峰。

Drugs covered by this patent

Patent Metadata

Patent number: CN104395307A
Jurisdiction: CN
Classification: —
Expires: 2015-03-04
Drug substance claim: No
Drug product claim: No
Assignee: Taiho Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.